Vitaped

   
Google
 
Web NewDrugInformation.com

Vitaped


Drug - Vitaped
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ascorbic Acid; Biotin; Cyanocobalamin; Ergocalciferol; Folic Acid; Niacinamide; Pantothenic Acid; Phytonadione; Pyridoxine; Riboflavin; Thiamine; Vitamin A Palmitate; Vitamin E
Multiple ingredients are in alphabetical order.

Strength - N/A,80MG/VIAL;N/A,0.02MG/VIAL;N/A,0.001MG/VIAL;400 IU/10ML,N/A;N/A,0.14MG/VIAL;N/A,17MG/VIAL;N/A,5MG/VIAL;0.2MG/10ML,N/A;N/A,1MG/VIAL;N/A,1.4MG/VIAL;N/A,1.2MG/VIAL;EQ 2,300 UNITS BASE/10ML,N/A;7 IU/10ML,N/A
The potency of the active ingredient(s), Ascorbic Acid; Biotin; Cyanocobalamin; Ergocalciferol; Folic Acid; Niacinamide; Pantothenic Acid; Phytonadione; Pyridoxine; Riboflavin; Thiamine; Vitamin A Palmitate; Vitamin E. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Vitaped. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020176
The FDA assigned number to Vitaped. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Vitaped. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 29, 1993
The date Vitaped was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Vitaped. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Vitaped is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Vitaped.

Vitaped


Mvc Plus 10mg/ml;0.006mg/ml;0.5ugm/ml;1.5mg/ml;20 Iu/ml;0.04mg/ml;4mg/ml;0.4mg/ml;0.36mg/ml;0.3mg/ml;330 Units/ml;1 Iu/ml Injectable; Injection
M.V.I. Adult 200mg/vial;0.06mg/vial;0.005mg/vial;15mg/vial;0.005mg/vial;0.6mg/vial;40mg/vial;6mg/vial;3.6mg/vial;6mg/vial;1mg/vial;10mg/vial;0.15mg/vial Injectable; Iv (infusion)
M.V.I. Adult (pharmacy Bulk Package) 200mg/5ml;0.06mg/5ml;0.005mg/5ml;15mg/5ml;0.005mg/5ml;0.6mg/5ml;40mg/5ml;6mg/5ml;3.6mg/5ml;6mg/5ml;1mg/5ml;10mg/5ml;0.15mg/5ml Injectable; Iv (infusion)
M.V.I.-12 20mg/ml;0.006mg/ml;0.5ugm/ml;1.5mg/ml;20 Iu/ml;0.6mg/ml;4mg/ml;0.4mg/ml;0.36mg/ml;0.6mg/ml;330 Units/ml;1 Iu/ml Injectable; Injection
M.V.I.-12 Lyophilized 100mg/vial;0.06mg/vial;0.005mg/vial;15mg/vial;5ugm/vial;0.4mg/vial;40mg/vial;4mg/vial;3.6mg/vial;3mg/vial;1mg/vial;10mg/vial Injectable; Injection
Vitaped N/a,80mg/vial;n/a,0.02mg/vial;n/a,0.001mg/vial;400 Iu/10ml,n/a;n/a,0.14mg/vial;n/a,17mg/vial;n/a,5mg/vial;0.2mg/10ml,n/a;n/a,1mg/vial;n/a,1.4mg/vial;n/a,1.2mg/vial;eq 2,300 Units Base/10ml,n/a;7 Iu/10ml,n/a Injectable; Injection
Berocca Pn 50mg/ml;0.03mg/ml;0.0025mg/ml;7.5mg/ml;100 Iu/ml;0.2mg/ml;20mg/ml;2mg/ml;1.8mg/ml;1.5mg/ml;1,650 Iu/ml;5 Iu/ml Injectable; Injection
M.V.C. 9+3 10mg/ml;0.006mg/ml;0.5ugm/ml;1.5mg/ml;20 Iu/ml;0.04mg/ml;4mg/ml;0.4mg/ml;0.36mg/ml;0.3mg/ml;330 Units/ml;1 Iu/ml Injectable; Injection
M.V.I.-12 10mg/ml;0.006mg/ml;0.5ugm/ml;1.5mg/ml;20 Iu/ml;0.04mg/ml;4mg/ml;0.4mg/ml;0.36mg/ml;0.3mg/ml;330 Units/ml;1 Iu/ml Injectable; Injection
M.V.I.-12 (without Vitamin K) 20mg/ml;0.006mg/ml;0.05ugm/ml;1.5mg/ml;0.0005mg/ml;0.06mg/ml;4mg/ml;0.6mg/ml;0.36mg/ml;0.6mg/ml;0.1mg/ml;1mg/ml Injectable; Injection

NewDrugInformation